← Leaderboards
Judy Anne Mikovits
Epigenx Pharmaceuticals
$1,744,687
Attributed
$1,912,487
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $335.6K · FY2009–10$500K$375K$250K$125K$0
'09
'10
Funding mix
By agency
NIH$1,912,487 · 4
By mechanism
R01$646,916 · 1
R44$644,711 · 1
R43$620,860 · 2
Top collaborators
- Jonathan Richard Kerr1 shared
Most similar at Epigenx Pharmaceuticals
Same institution · by research overlap
- Paul H Johnson$1,023,432
Others in their field
Top investigators on “Neoplasm /Cancer Pharmacology”
- Constance Ann Benson · University Of California, San Diego$110,607,997
- Gregory H Reaman · National Childhood Cancer Foundation$80,145,837
- Richard L Schilsky · University Of Chicago$72,058,991
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Leland H Hartwell · Fred Hutchinson Cancer Research Center$22,238,492
- Philip J Disaia · University Of California Irvine$19,978,203
Research focus
Neoplasm /Cancer PharmacologyAntineoplasticsCombinatorial ChemistryDna MethylationGene ExpressionEnzyme InhibitorsMethyltransferase3t3 CellsChemical Registry /ResourceDrug Discovery /IsolationGreen Fluorescent ProteinsBody SystemAcuteAntibodiesBiotherapeutic AgentCisplatinBiomarkerAmericanChronicBioassayChemokineChronic Fatigue SyndromeAids Related Neoplasm /CancerAffect
Grant awards (8)
New Strategies to Decipher the Pathophysiology of Chronic Fatigue Syndrome$311,316
R01 · FY2010 · AI · contact PI
New Strategies to Decipher the Pathophysiology of Chronic Fatigue Syndrome$335,600
R01 · FY2009 · AI · contact PI
Development of Inhibitors of the DNA Methylation Process$251,011
R44 · FY2004 · CA
Development of Inhibitors of the DNA Methylation Process$16,000
R44 · FY2004 · CA
Development of Inhibitors of the DNA Methylation Process$377,700
R44 · FY2003 · CA
Development of DNA Methyltransferase Inhibitors as Anti*$227,827
R43 · FY2003 · CA
Development of DNA Methyltransferase Inhibitors as Anti*$227,827
R43 · FY2002 · CA
DEVELOPMENT OF INHIBITORS OF THE DNA METHYLATION PROCESS$165,206
R43 · FY2001 · CA